Anyone that has embarked on the complex journey of drug development is facing a global paradox: drug development is an excruciatingly slow process taking place in a rapidly changing environment. Some of the changes are so profound that they impact the drug development process in its globality. They have multiple origins and consequences touching upon very different domains: personalized medicine, disease taxonomy, biomarkers, translational pharmacology, patient-centered clinical development, big data management, reproducible research, pharmacoeconomics, and others. There is only one way to reduce the risks associated with these paradigm changers and make all the difference between success and failure: anticipate what may lie ahead and adapt one’s strategy accordingly. The present event will help you do just that.
